MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitro
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 37 (11) , 1579-1584
- https://doi.org/10.1053/jpsu.2002.36188
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastomaEuropean Journal Of Cancer, 1997
- Cremophor EL reversed multidrug resistance in vitro but not in tumor-bearing mouse modelsAnti-Cancer Drugs, 1996
- MDR1 gene expression in solid tumoursEuropean Journal Of Cancer, 1996
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- Adding a Reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenograftsEuropean Journal Of Cancer, 1995
- Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma—A report from the German Cooperative Pediatric Liver Tumor Study HB-89Journal of Pediatric Surgery, 1995
- Ergebnisse der Studie HB-89 bei der Behandlung maligner epithelialer Lebertumoren des Kindesalters und Konzept eines neuen Protokolls HB-94Klinische Padiatrie, 1994
- Chemotherapy can convert unresectable hepatoblastomaJournal of Pediatric Surgery, 1992
- The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapyJournal of Pediatric Surgery, 1991
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983